The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...

Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...

Anbio Biotechnology NNNN IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN. The company is offering shares at an expected price between $5.00 and $6.00 per share with an ...

The most notable insider purchases of the past week came from return buyers, including Warren Buffett. A biotech IPO also ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

The heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for ...

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

A total of 66 companies have submitted applications for IPOs, with highly anticipated offerings from Hero Fincorp and LG ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, ...